{"accessLevel": "public", "bureauCode": ["010:12"], "contactPoint": {"@type": "vcard:Contact", "fn": "Barnett A Rattner", "hasEmail": "mailto:brattner@usgs.gov"}, "description": "Trial examining blood clotting function response in kestrels initially fed a diet containing chlorophacinone (CPN) or brodifacoum (BROD), and following a recovery period, kestrels were challenged with a diet containing chlorophacinone.  Kestrels received two 25 \u00b1 0.1 g NBP meatballs daily for a 7-day period containing either vehicle, 1.5 \u00b5g CPN/g wet wt diet (i.e., 1.5 ppm chlorophacinone) or 0.5 \u00b5g brodifacoum/g wet wt (i.e., 0.5 ppm brodifacoum) during an initial exposure phase.  Following 7 day recovery period, these kestrels were then fed 0.75 \u00b5g CPN/g wet wt diet (i.e., 0.75 ppm chlorophacinone) for a 7 day challenge exposure phase.  Hereafter, these groups are designated control-chlorophacinone challenge (CON-CPN), chlorophacinone-chlorophacinone challenge (CPN-CPN), and brodifacoum-chlorophacinone challenge (BROD-CPN).", "distribution": [{"@type": "dcat:Distribution", "accessURL": "https://doi.org/10.5066/P9707L0Q", "description": "Landing page for access to the data", "format": "XML", "mediaType": "application/http", "title": "Digital Data"}, {"@type": "dcat:Distribution", "description": "The metadata original format", "downloadURL": "https://data.usgs.gov/datacatalog/metadata/USGS.5d4d97e1e4b01d82ce8e0633.xml", "format": "XML", "mediaType": "text/xml", "title": "Original Metadata"}], "identifier": "http://datainventory.doi.gov/id/dataset/USGS_5d4d97e1e4b01d82ce8e0633", "keyword": ["Birds", "USGS:5d4d97e1e4b01d82ce8e0633", "anticoagulant", "brodifacoum", "chlorophacinone", "clotting time", "hazard", "non-target effects", "risk", "secondary poisoning"], "modified": "2020-09-22T00:00:00Z", "publisher": {"@type": "org:Organization", "name": "U.S. Geological Survey"}, "spatial": "-76.82396, 39.02719, -76.7395, 39.09063", "theme": ["geospatial"], "title": "Brodifacoum toxicity in American kestrels (Falco sparverius) with evidence of increased hazard upon subsequent anticoagulant rodenticide exposure - Results of trial 3"}